Concomitant Isolation of Primary Astrocytes and Microglia for Protozoa Parasite Infection
March 18th, 2020
7.3K views
The overall goal of this protocol is to instruct how to extract, maintain, and dissociate murine astrocyte and microglia cells from the central nervous system, followed by infection with protozoa parasites.
Overview
This article presents a detailed protocol for the parallel extraction, culture, and infection of primary murine astrocytes and microglia from newborn mouse cortices. The method enables researchers to obtain both glial cell types from the same extraction, facilitating comparative studies of their roles in central nervous system (CNS) infections, particularly with protozoan parasites such as Trypanosoma cruzi and Toxoplasma gondii. The protocol includes steps for cell isolation, culture maintenance, phenotyping, infection, and analysis of infection rates using fluorescence microscopy.
Key Study Components
Area of Science
- Neuroimmunology
- Cell Biology
- Parasitology
Background
- Astrocytes and microglia are the most abundant glial cells in the CNS, essential for physiological support and homeostasis.
- Both cell types play significant roles in the immune response to CNS infections.
- Improved methods for isolating and studying these cells are needed to better understand their responses to pathogens.
- Protozoan infections, such as those caused by T. cruzi and T. gondii, can significantly impact CNS function.
Purpose of Study
- To provide a reproducible and efficient protocol for the simultaneous extraction and culture of astrocytes and microglia from mouse cortices.
- To enable comparative studies of glial cell responses to protozoan infections.
- To facilitate downstream analyses of glial cell function during infection.
Methods Used
- Extraction of cortices from newborn mice under sterile conditions.
- Enzymatic and mechanical dissociation of brain tissue to obtain single-cell suspensions.
- In vitro culture of glial cells with periodic media replacement for 14 days.
- Mechanical dissociation to separate microglia from astrocytes.
- Phenotyping of cell populations by flow cytometry.
- Infection of cultured cells with T. cruzi and T. gondii parasites.
- Assessment of infection rates using fluorescence microscopy with genetically modified or antibody-labeled parasites.
Main Results
- The protocol yields high-purity populations: approximately 89.5% astrocytes and 96.6% microglia.
- Both cell types can be efficiently infected with protozoan parasites in vitro.
- Fluorescence microscopy enables clear visualization and quantification of infection rates at multiple time points.
- The method supports additional analyses such as ELISA, Western blotting, and qPCR for functional studies.
Conclusions
- This protocol provides a simple, cost-effective, and efficient approach for isolating and studying primary murine astrocytes and microglia.
- It enables direct comparison of glial cell responses to CNS infections.
- The technique opens new avenues for neuroimmunological research on glial cell function during infection and disease.
Frequently Asked Questions
What is the main advantage of this protocol over previous methods?
This protocol allows for the simultaneous extraction and isolation of both astrocytes and microglia from the same mouse cortices, optimizing animal use and enabling direct comparative studies.
How are astrocytes and microglia separated after culture?
After 14 days in culture, mechanical dissociation using an orbital shaker separates microglia from astrocytes, followed by trypsinization to detach astrocytes.
What types of infections can be studied using this protocol?
The protocol is suitable for studying infections by protozoan parasites such as T. cruzi and T. gondii, and can be adapted for other pathogens affecting the CNS.
How is infection rate assessed in glial cells?
Infection rates are determined by fluorescence microscopy using genetically modified parasites expressing fluorescent proteins or parasites labeled with specific fluorescent antibodies.
What purity levels are achieved for astrocyte and microglia populations?
The protocol yields astrocyte populations with approximately 89.5% purity and microglia populations with about 96.6% purity.
Can this protocol be used for downstream molecular analyses?
Yes, the isolated cells can be used for ELISA, Western blotting, and real-time quantitative PCR to study cytokine production, protein expression, and gene transcription.
What precautions should be taken when handling protozoan parasites?
Since protozoan parasites can infect human cells, strict biosafety measures should be followed during all handling and infection procedures.
Executive Industry Relevance
This protocol enables biopharma R&D teams to simultaneously isolate primary astrocytes and microglia from murine cortices, supporting comparative glial cell analysis in CNS infection models. By optimizing animal use and providing a standardized workflow for phenotyping and infection, the method enhances target validation and mechanistic de-risking in neuroimmunology and infectious disease research. The approach supports early discovery efforts focused on glial-mediated pathogen control and host-pathogen interactions.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of glial cell responses to protozoan parasites like T. cruzi and T. gondii to clarify pathogenic mechanisms in CNS infections.
- Operational Value: Supports functional target validation by allowing side-by-side comparison of astrocyte and microglia infection rates and parasite control.
- Predictive Confidence: Facilitates phenotypic screening of glial-mediated immune responses to de-risk targets in neurodegenerative and infectious disease programs.
Screening & Assay Development
- Assay Readiness: Generates purified glial cell populations with >89% astrocyte and >96% microglia purity, enabling reproducible infection assays.
- Quantitative Outputs: Supports fluorescence microscopy-based infection rate quantification at multiple time points for dose- and time-dependent analysis.
- Scalability: Uses standard cell culture equipment and reagents, allowing adaptation to multi-well formats for compound screening.
Translational & Preclinical Research
- Disease-Relevant System: Provides a murine glial cell model to study CNS-relevant protozoan infections with translational relevance to human neuroinflammatory conditions.
- Mechanistic De-risking: Enables evaluation of glial contributions to pathogen clearance, supporting biomarker discovery and pathway analysis.
- Preclinical Continuity: Supports longitudinal infection tracking from 2 to 96 hours, aligning with preclinical evaluation windows for therapeutic candidates.
Pipeline & Workflow Integration
The method integrates into early discovery workflows by supplying validated glial cells for infection modeling, assay development, and mechanistic studies prior to lead optimization.
- Discovery Biology: Supports hypothesis testing on glial cell-specific roles in pathogen invasion and replication within the CNS.
- Screening: Delivers standardized, phenotyped glial cells ready for infection assays with fluorescent or antibody-labeled parasites.
- Analytics: Enables quantitative infection rate measurement via fluorescence microscopy and downstream analysis of cytokine, protein, and RNA expression.
- Translational Research: Connects glial infection responses to broader neuroimmune mechanisms relevant to preclinical disease models.
- Enterprise Reuse: Establishes a reusable glial cell isolation platform applicable across viral, parasitic, and neurodegenerative disease programs.
Operational & Enterprise Impact
- Scientific Value: Reduces mechanistic ambiguity in glial cell function during infection by enabling direct comparison of astrocytes and microglia from the same animal.
- Operational Value: Improves reproducibility and standardization through a unified extraction protocol minimizing inter-animal variability.
- Strategic Value: Informs go/no-go decisions by providing early predictive data on glial-mediated pathogen control in CNS infection models.
- Portfolio Impact: Supports risk-adjusted prioritization of targets based on glial cell responsiveness to protozoan challenge.
Implementation Considerations
- Requires expertise in aseptic tissue dissection, enzymatic digestion, and mechanical dissociation techniques.
- Depends on access to centrifuges, incubators, orbital shakers, and fluorescence microscopy for infection readouts.
- Necessitates standardization of media changes, washing steps, and dissociation timing across batches for consistent glial yields.
- Involves adaptation considerations when extending the protocol to other glial subtypes or disease models beyond protozoan infection.
- Limited by the 14-day culture timeline and mechanical dissociation step, which may affect scalability for high-throughput applications.
Biopharma FAQs
Why does simultaneous isolation of astrocytes and microglia matter for target validation?
Simultaneous isolation allows direct comparison of glial cell responses to infection from the same animal, reducing biological variability and improving the reliability of target validation assays in neuroimmunology.
How does mechanical dissociation on day 14 enable comparative glial cell analysis?
Mechanical dissociation separates microglia from astrocytes after co-culture, enabling harvest of purified populations for infection studies and side-by-side comparison of parasite uptake and replication.
What quantitative measurements does fluorescence microscopy enable after protozoan infection?
Fluorescence microscopy allows quantification of infection rates at 2, 48, and 96 hours using fluorescently labeled parasites, supporting time-dependent analysis of glial cell pathogen control.
Why are replication requirements important for cross-functional collaboration in glial infection studies?
Replication ensures consistent glial purity and infection rates across experiments, enabling reliable data sharing between discovery, screening, and preclinical teams working on CNS infection models.
What statistical analysis capabilities are needed before implementing this glial infection assay?
Teams require the ability to quantify infection percentages, compare mean fluorescence intensity across conditions, and apply t-tests or ANOVA to assess significant differences in glial cell pathogen responses.
